2015
DOI: 10.1021/acs.jafc.5b04312
|View full text |Cite
|
Sign up to set email alerts
|

Guidelines for Research on Bioactive Constituents – A Journal of Agricultural and Food Chemistry Perspective

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
23
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 9 publications
(23 citation statements)
references
References 22 publications
0
23
0
Order By: Relevance
“…Among these compounds, proanthocyanidins have attracted considerable attention in recent years due to their human health benefits such as reducing cardiovascular diseases, carcinogenesis, neurodegeneration, skin deterioration, diabetic or anti-hyperglycaemic problems, as well as their anti-tyrosinase activities. 16,17 Proanthocyanidins (PAs) are composed of flavan-3-ol monomer units (catechin or epicatechin) linked mainly through C4-C8 or C4-C6 interflavan bonds, 18 which form oligomeric proanthocyanidins and polymeric proanthocyanidins. 19 PAs have properties such as forming stable complexes with metal ions and proteins, and act as good reducing agents.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Among these compounds, proanthocyanidins have attracted considerable attention in recent years due to their human health benefits such as reducing cardiovascular diseases, carcinogenesis, neurodegeneration, skin deterioration, diabetic or anti-hyperglycaemic problems, as well as their anti-tyrosinase activities. 16,17 Proanthocyanidins (PAs) are composed of flavan-3-ol monomer units (catechin or epicatechin) linked mainly through C4-C8 or C4-C6 interflavan bonds, 18 which form oligomeric proanthocyanidins and polymeric proanthocyanidins. 19 PAs have properties such as forming stable complexes with metal ions and proteins, and act as good reducing agents.…”
Section: Introductionmentioning
confidence: 99%
“…Many classes of polyphenols, classically distinguished as flavonoids and non‐flavonoids, are known to be present in many plant tissues. Among these compounds, proanthocyanidins have attracted considerable attention in recent years due to their human health benefits such as reducing cardiovascular diseases, carcinogenesis, neurodegeneration, skin deterioration, diabetic or anti‐hyperglycaemic problems, as well as their anti‐tyrosinase activities . Proanthocyanidins (PAs) are composed of flavan‐3‐ol monomer units (catechin or epicatechin) linked mainly through C4–C8 or C4–C6 interflavan bonds, which form oligomeric proanthocyanidins and polymeric proanthocyanidins .…”
Section: Introductionmentioning
confidence: 99%
“…However, considering the complexity of the design (e.g., gender and body mass difference, consumed resveratrol concentration, and diet), this study included a rather low number of participants, which challenges the ability to evaluate the effects, as the data may be dominated by interindividual variations in metabolic systems and in resveratrol bioavailability. Therefore, the scientific community dealing with bioactive compounds is now urging that more research be conducted to demonstrate the bioavailability of bioactive constituents in relevant in vitro and in vivo models …”
Section: Current Status Of Resveratrol Researchmentioning
confidence: 99%
“…In both guidelines, the bioavailability of the flavonoids in question should be strictly considered when planning and reporting results from in vitro experiments. According to Somoza et al (61) , studies should address five focus areas when reporting in vitro bioactivity of plant-based bioactive components: (1) Identification of the active molecule/s using state-of-art spectrometric and spectroscopic techniques; (2) Quantitation of the active components using validated methods; (3) Demonstration of the bioavailability of the bioactive component using relevant in vitro or in/ex vivo models; (4) Unequivocal identification and quantitation of metabolites generated in the bioavailability study; (5) Mechanistic study using the relevant compound.…”
Section: Use Of Flavonoid-rich Plant Extracts For Bioactivity Assaysmentioning
confidence: 99%
“…Recently, guidelines and recommendations in reporting requirements for bioactive components, such as flavonoids have been published ( 61 , 62 ) . In both guidelines, the bioavailability of the flavonoids in question should be strictly considered when planning and reporting results from in vitro experiments.…”
Section: Use Of Flavonoid-rich Plant Extracts For Bioactivity Assaysmentioning
confidence: 99%